Cooperative Agreement 70NANB22H017
Award Date
3/1/22
Completion Date
2/28/25
Dollars Obligated
$4.1M
Federal Agency
National Institute of Standards and Technology
Federal Grant Program
11.619
Assistance Type
Cooperative Agreement
Place of Performance
St Paul, MN 55108, USA
Similar Awards
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will provide $2,178,000 to develop a "tunable nanophage platform" for rapid vaccine development against emerging infectious diseases, including SARS-CoV-2 variants and pre-emergent SARS-like coronaviruses. The key products to be delivered under this award include engineered "second generation" nanophages...
This $980,779 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) aims to develop a deployable and adaptable plasmonic sensing platform for infectious disease surveillance. The primary objectives are to create catalytic surface-enhanced Raman scattering (SERS) sensors using functional DNA sequences to enable highly multiplexed,...
This $15,981,588 project grant from the National Institutes of Health's National Institute of Allergy and Infectious Diseases aims to develop pan-coronavirus vaccines. Led by Washington University, the collaborative program includes eleven laboratories seeking to design optimized B and T cell antigens conferring broad immunity against sarbecoviruses and merbecoviruses. The three-year award beginning September 2022 supports three integrated research projects and two centralized cores. Project 1...
This Project Grant award, funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to identify and design broadly acting antibodies targeting the highly conserved S2 subunit of the SARS-CoV-2 spike protein. With a total funding of $199,584, the award will support a 4-year research project at the Albert Einstein College of Medicine in New York to evaluate the functional properties of these...
This $1,000,000 Cooperative Agreement, awarded by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084), supports the lead optimization of a novel, broad-spectrum antiviral and immunomodulatory agent to combat coronaviruses, including SARS-CoV-2. The project, conducted by Akanocure Pharmaceuticals Inc., aims to develop an orally administered drug candidate that can suppress viral replication and restore immune system homeostasis,...
This federal Project Grant award, funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports the development of a pioneering class of nanobodies designed to provide comprehensive protection against all betacoronaviruses, including SARS-CoV-1, MERS-CoV, and SARS-CoV-2. The $867,563 award to Rockefeller University aims to strategically expand upon existing nanobody repertoires to identify,...
This $788,406 project grant from the National Institutes of Health National Institute of Allergy and Infectious Diseases, under the Allergy and Infectious Diseases Research program (CFDA 93.855), will fund the development of a sensitive, direct reading bioaerosol detection platform to quantify airborne pathogens such as SARS-CoV-2. Aerosol Devices Inc. will integrate their gentle condensation-growth capture sampler, which concentrates intact, viable virus particles into a small liquid volume...
This R21 project grant, awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support a 2-year investigation of SARS-CoV-2 spike protein structure and function. The $873,600 award will enable experiments to analyze the effects of spike protein mutations on receptor binding and antibody neutralization, as well as probe the conformational states of the spike protein trimer. The project will also...
This federal Cooperative Agreement award, titled "SCIENTIFIC PLATFORM FOR HIGH EFFICACY ANTIGEN DESIGN VIA ROBUST INTEGRATION OF COMPUTATIONAL EXPERIMENTS, AI, AND PROTEIN MODELING (SPHERICAL)", is funded by the National Institutes of Health (NIH) through the Advanced Research Projects Agency for Health (ARPA-H) federal grant program (CFDA 93.384). The $26,679,771.00 award, granted on August 27, 2024, will support the development of a scientific platform that integrates computational...
This Project Grant award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $273,550 to Biocognon LLC to develop a combinatorial high-throughput platform for generating improved molecular recognition components for use in therapeutic and diagnostic antibodies. The core aim is to utilize breakthroughs in DNA sequencing, synthetic biology, and computational biology to efficiently identify and optimize antibody...